KalVista Pharmaceuticals, Inc.KALVNASDAQ
Loading
Cash Flow PerformanceFair Value
Percentile Rank42
Studio
Year-over-Year Change

Free cash flow yield

Latest
-22.43%
↓ 17% vs avg
Percentile
P42
Within normal range
Streak
1 yr
Consecutive declineFair Value
Average
-19.21%
Historical baseline
PeriodValueYoY Change
2025-22.43%-4.4%
2024-21.48%+30.5%
2023-30.91%-21.8%
2022-25.38%-300.0%
2021-6.35%+72.7%
2020-23.26%-115.4%
2019-10.80%-217.4%
20189.20%+127.2%
2017-33.79%-25.5%
2016-26.93%-